Cheryl R. Blanchard

Dr. Blanchard has been a member of the Company’s Board of Directors since May 2013. In April 2020, Dr. Blanchard was appointed as President and Chief Executive Officer of Anika Therapeutics, after serving as interim Chief Executive Officer since February 2020. Prior to that, she served as President and Chief Executive Officer of Microchips Biotech, Inc., a venture-backed biotechnology company developing regenerative medicine and drug delivery products developed in the MIT laboratory of Dr. Robert Langer., from 2014 until its sale to Daré Bioscience, Inc. in November 2019. Prior to thereto since 2009, she served as Senior Vice President & Chief Scientific Officer of Zimmer, Inc., a large orthopedic implants company based in Warsaw, IN. From 2005 to 2009, Dr. Blanchard served as Sr. VP Research and Development & CSO of Zimmer, and before then since 2000 she held increasingly responsible research and operational posts at Zimmer. From 1986 to 2000, Dr. Blanchard served in several research and senior management roles at Southwest Research Institute in San Antonio, a large contract R&D organization. She has a Ph.D. and M.S. in Materials Science & Engineering from the University of Texas at Austin and a B.S. in Ceramic Engineering from Alfred University in New York.